Loading provider…
Loading provider…
Gynecologic Oncology Physician in Billings, MT
NPI: 1003179581Primary Practice Location
INTERMOUNTAIN HEALTH ST VINCENT REGIONAL HOSPITAL
1233 N 30th St, Billings, MT
Primary Employer
St Vincent Healthcare
intermountainhealthcare.org
HQ Phone
Get MD Elizabeth's Phone Numberphone_androidMobile
Get MD Elizabeth's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
MT State Medical License
MT State Medical License
2019 - 2027
ND State Medical License
2024 - 2026
WY State Medical License
2022 - 2026
OH State Medical License
2016 - 2021
RI State Medical License
2012 - 2016

American Board of Obstetrics and Gynecology
Gynecologic Oncology

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology
Women and Infants Hospital of Rhode Island/Brown University
Residency • Obstetrics and Gynecology
2012 - 2016
UVA School of Medicine
med.virginia.edu
Medical School
Until 2012
Cleveland Clinic Foundation
Fellowship • Gynecologic Oncology
Until 2019
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 96 | 104 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 56 | 70 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 40 | 40 |
| 4 | 58571Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | 22 | 22 |
| 5 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 15 | 16 |
Management Strategies for Recurrent Endometrial Cancer
Authors: Connor, Elizabeth V, Rose, Peter G
Journal: Expert Rev Anticancer Ther
Publication Date: 2018-07-04
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
Authors: Katie K. Crean-Tate, Chad Braley, Goutam Dey, Emily Esakov, Caner Saygin, Alexandria Trestan, Daniel J. Silver, Soumya M. Turaga, Elizabeth V. Connor, Robert Debernardo, Chad M. Michener, Peter G. Rose, Justin D. Lathia, Ofer Reizes
Publication Date: 2021-04
Predicting non-home discharge in epithelial ovarian cancer patients: External validation of a predictive model.
Authors: Erica Newlin
Publication Date: 2018-06-20